Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

TRAW Traws Pharma, Inc. Common Stock
$0.34 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TRAW stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Traws Pharma, Inc. Common Stock (TRAW)

Loading

Key Stats

Market cap. 5.2M
Enterprise value 247.6K
Trailing PE 1.9390244
Forward PE -0.18218085
PEG Ratio 0.0426585368
Enterprise to EBITDA -0.012
Enterprise to revenue 0.08875770609319
Price to book MRQ 3.0855856
Price to sales TTM 1.8728365591398

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 2.8M
EBITDA -21397000
Diluted EPS TTM -1.71
Total Cash (MRQ) 5.0M
Current ratio (MRQ) 0.927
Operating Cash Flow (TTM) -16849000

TRAW trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TRAW News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.